| http://www.w3.org/ns/prov#value | - l manner; that we can develop a DNA-based orthobiologics product portfolio; that FDA or other regulatory clearances or other certifications, or other commercialization efforts will be successful or will effectively enhance our businesses or their market value; that our products or product candidates will prove to be sufficiently safe and effective after introduction into a broader patient populati
|
